The city of Chicago, Illinois, currently has 15 active clinical trials seeking participants for Asthma research studies.
Chicago Asthma School-Directed Child-Centered Assessment and Dissemination of Evidence
Recruiting
Research has shown that adherence to evidence-based asthma guidelines leads to improved outcomes, yet critical gaps remain in the implementation of these guidelines, particularly among minority and low-income youth. Schools represent a crucial point of intervention, as demonstrated by school-based asthma programs that have addressed individual components of the guidelines with promising results. This project aims to develop, implement, and evaluate a pragmatic, multi-component asthma program tha... Read More
Gender:
All
Ages:
4 years and above
Trial Updated:
05/08/2024
Locations: University of Chicago Charter Schools, Chicago, Illinois
Conditions: Asthma in Children
Physical Activity Intervention for Black Women With Asthma
Recruiting
Physical inactivity is associated with poor asthma control and quality of life, and greater health care utilization. Rates of physical inactivity, asthma, and asthma mortality among Black women are higher than those of their White counterparts. Our formative work identified barriers to PA among Black women with asthma including a lack of social support, self-efficacy, unsafe neighborhood and fear related to experiences with life-threatening asthma exacerbations. Given the unique barriers to PA a... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
05/06/2024
Locations: University of Illinois Chicago, Chicago, Illinois +1 locations
Conditions: Asthma
Protocol CAUSE-03 / CHEETAH
Recruiting
This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot have used asthma medications in the year prior to enrollment and cannot demonstrate bronchodilator reversibility at baseline. Phenotypic characteristics will be established at baseline, and the partici... Read More
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
05/02/2024
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology, Chicago, Illinois
Conditions: Asthma